4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 12:54 pm US/Eastern
Search
Dynamic quotes   
On
 | Off
  • Technical Analysis
  • Market Quotes
  • Market News
  • Market Screeners and Tools

4-Traders Homepage  >  Shares  >  Nasdaq  >  PONIARD PHARMACEUT   PARD   US7324493011

PONIARD PHARMACEUT (PARD)

  
Real time Streaming quotes -
Delayed Quote. Delayed Nasdaq - 09/03 12:38:13 pm
0.4695 USD   -0.11%
08/09PONIARD PHARMACEUT: Poniard Pharmaceuticals Reports Second Quarter 2010 Financi..
08/02PONIARD PHARMACEUT: Poniard Pharmaceuticals to Host Second Quarter 2010 Financi..
07/22PONIARD PHARMACEUT: Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice R..
SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
 NewsRSS News
Latest news on PONIARD PHARMACEUT
08/09Poniard Pharmaceuticals Reports Second Quarter 2010 Financial Results
08/02Poniard Pharmaceuticals to Host Second Quarter 2010 Financial Results Conference..
07/22Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid..
05/03Poniard Pharmaceuticals to Host First Quarter 2010 Financial Results Conference ..
03/18U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition..
03/15Poniard Pharmaceuticals Announces $6.3 Million Financing
03/01Poniard Pharmaceuticals to Host Fourth Quarter and Year End 2009 Financial Resul..
02/23Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
02/05Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conferenc..
02/03Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
2009Poniard Pharmaceuticals Announces $6.5 Million Financing
2009Poniard Announces $7.4 Million Financing
2009Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Tr..
2009Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial of Picoplatin in S..
2009Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern..
2009Poniard Pharmaceuticals to Present Updated Clinical Data from Phase 2 Trial of P..
2009Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provide..
2009Poniard Pharmaceuticals to Host Third Quarter 2009 Financial Results Conference ..
2009Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conferen..
2009Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in Sep..
2009Poniard Pharmaceuticals Secures $60 Million Committed Equity Financing Facility
2009Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in Augus..
2009Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference..
2009Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin P..
2009Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
2009Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Confe..
2009Poniard Pharmaceuticals Files Shelf Registration
2009Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conf..
2009Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
2009Poniard Pharmaceuticals to Host First Quarter 2009 Financial Results Conference ..
2009Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal ..
2009Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin..
2009Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candid..
2009Poniard Pharmaceuticals to Present at Needham & Company's Cancer Therapeutics: T..
2009Poniard Pharmaceuticals Receives Going Concern Qualification
2009Poniard Pharmaceuticals Reschedules Fourth Quarter and Fiscal 2008 Results Confe..
2009Poniard Pharmaceuticals to Host Fourth Quarter and Year-End 2008 Financial Resul..
2009Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial ..
2009Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
2008Poniard Pharmaceuticals Announces Management Changes and Focus on Development an..
2008Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
2008Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demo..
2008Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corpora..
2008Poniard Pharmaceuticals Announces Upcoming Conference Participation
2008Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference ..
2008Poniard Pharmaceuticals' Picoplatin Named by Windhover Among Top 10 Most Promisi..
2008Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Confer..
2008Poniard Pharmaceuticals Announces Upcoming Conference Participation
2008Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center T..
2008Poniard Pharmaceuticals Announces Upcoming Conference Participation
1  2Next
Chart PONIARD PHARMACEUT
Short term
Mid-term
Long term
Graphique historique des cours de bourse de PONIARD PHARMACEUT
Full-screen chart
Income Statement Evolution
PONIARD PHARMACEUT : Income Statement Evolution
More Fundamentals
EPS Reviews
PONIARD PHARMACEUT : EPS Reviews
More Estimates Reviews
Price share PONIARD PHARMACEUT (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /